R&D
Research and Development
Incorporating digital excellence to boost R&D
In life sciences, time-to-market is a vital parameter for all R&D functions. Though there are plenty of digital solutions available to meet this end, succeeding takes more than implementing them.
At NNIT, we can help you build a tech-empowered value chain, across your Clinical, Regulatory Affairs, and Drug Safety functions. Uniquely, you get leading specialists in all three domains, plus implementation and business processes specialists. We not only implement tech but incorporate digital excellence to boost your R&D.
Build a tech-empowered value chain
Getting the best out of digital solutions in life sciences takes more than implementing them. Internal processes, and capabilities must be closely aligned with the specific demands in every part of your value chain.
With NNIT, you get a proven transformation solution to not only implement tech but incorporate digital excellence. Uniquely, we offer an amalgam of leading specialists in implementation, business processes, and every key life sciences domain - to help you build a tech-empowered value chain.
Life Sciences, Quality, Veeva Solutions
From Retrospective Control to Predictive Assurance: How AI Is Changing What It Means to Be in Control
Life Sciences, Clinical, Compliance, Digital Manufacturing, Quality, Regulatory Affairs, Smart supply-chain
Webinar: Inside the NDC-12 Industry Pilot
Life Sciences, Clinical, Regulatory Affairs
Webinar: Content Governance in the Age of AI: Preparing Pharmaceutical Organisations for ePI and FHIR I by Docuvera & NNIT
Life Sciences, AI
Webinar: Experience AI that Solves your Life Sciences Challenges
Life Sciences, AI, Digital Manufacturing
Accelerating PAS-X Upgrades with Structured AI Automation
Life Sciences, Digital Manufacturing, Quality, Regulatory Affairs
The Data Revolution in Pharma: How FHIR enables next level business outcomes for Quality, Manufacturing, and Regulatory
Life Sciences, Data, Regulatory Affairs, Smart supply-chain
The NDC-12 Cross-Industry Pilot: Key Findings & Insights From Phase 0
Life Sciences, AI, Data
From Hype to Reality: Architectural, Strategic, and Data Lessons for AI in Pharma
Life Sciences, Private, Public, AI
Agentic AI vs. AI Agents: Why This Distinction Matters Across Regulated Industries